RIGOTTI, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 2.547
NA - Nord America 2.519
EU - Europa 2.135
SA - Sud America 369
AF - Africa 56
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.630
Nazione #
US - Stati Uniti d'America 2.442
RU - Federazione Russa 1.357
SG - Singapore 1.013
CN - Cina 949
BR - Brasile 315
RO - Romania 269
HK - Hong Kong 257
VN - Vietnam 157
IT - Italia 131
FR - Francia 122
DE - Germania 70
GB - Regno Unito 47
IN - India 39
CA - Canada 38
BD - Bangladesh 26
ZA - Sudafrica 26
MX - Messico 23
NL - Olanda 23
AR - Argentina 21
SE - Svezia 21
FI - Finlandia 20
PL - Polonia 20
AT - Austria 16
IQ - Iraq 14
ES - Italia 13
TR - Turchia 13
EC - Ecuador 11
DZ - Algeria 10
JP - Giappone 10
ID - Indonesia 9
MY - Malesia 9
AE - Emirati Arabi Uniti 7
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
VE - Venezuela 6
CO - Colombia 5
MA - Marocco 5
OM - Oman 5
TN - Tunisia 5
CR - Costa Rica 4
KE - Kenya 4
PH - Filippine 4
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
LB - Libano 3
PE - Perù 3
UA - Ucraina 3
AQ - Antartide 2
AZ - Azerbaigian 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MK - Macedonia 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
Totale 7.630
Città #
Dallas 1.162
Singapore 514
San Jose 389
Moscow 329
Hong Kong 255
Ashburn 222
Shanghai 218
Hefei 115
Lauterbourg 99
Beijing 78
Ho Chi Minh City 53
New York 46
Hanoi 41
Los Angeles 41
Guangzhou 35
Boardman 30
Chennai 27
Milan 25
São Paulo 24
Brooklyn 23
Johannesburg 23
Santa Clara 21
Shenzhen 19
Nuremberg 18
Munich 17
Amsterdam 16
Chicago 16
London 16
Orem 16
Rome 16
Warsaw 16
Council Bluffs 15
Montreal 13
Omaha 13
Assago 12
Helsinki 12
Rio de Janeiro 12
Mexico City 11
Stockholm 11
Atlanta 10
Boston 10
Frankfurt am Main 10
Phoenix 10
Poplar 10
Tokyo 10
Toronto 10
Belo Horizonte 9
Da Nang 8
Haiphong 8
Houston 8
Jiaxing 8
Manchester 8
Paris 8
San Francisco 8
Algiers 7
Charlotte 7
Denver 7
Kuala Lumpur 7
Seattle 7
Washington 7
Baghdad 6
Brasília 6
Cesano Boscone 6
Guarulhos 6
Porto Alegre 6
Quito 6
Thái Nguyên 6
Wuxi 6
Ankara 5
Brescia 5
Campinas 5
Curitiba 5
Fuzhou 5
Hangzhou 5
Lawrence 5
Princeton 5
Reston 5
Tashkent 5
Vienna 5
Buenos Aires 4
Buffalo 4
Dhaka 4
Dubai 4
Fortaleza 4
Guayaquil 4
Lappeenranta 4
Muscat 4
Nairobi 4
Turku 4
Uberlândia 4
West Jordan 4
Birmingham 3
Bologna 3
Bến Tre 3
Carney 3
Changsha 3
Charleston 3
Chongqing 3
Florianópolis 3
Foshan 3
Totale 4.374
Nome #
105.3: Analysis of Autoimmune Re-activation After COVID-19 mRNA Vaccination in Pancreas Transplant Recipients 1.383
ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome 100
Acute rejection features in dual kidney transplant recipients fromelderly donors: comparison of calcineurin inhibitor-based and calcineurininhibitor-free immunosuppressive protocols 97
First World Consensus Conference on Pancreas Transplantation: Part II - recommendations 96
COVID-19 and kidney transplantation: an Italian Survey and Consensus 93
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients 92
C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients:single-center incidence and outcome 91
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment 87
The era of the new directly acting antivirals: Has the time come for kidney transplant only in compensated cirrhosis? 87
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 85
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 84
Kidney Donation after circulatory death: The Veneto Region experience in Italy 84
ADVANTAGES OF PSI plus LOW-DOSE CNI VS PSI ALONE IN DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS 83
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 83
Alefacept Combined With Tacrolimus, Mycophenolate Mofetil and Steroids in De Novo Kidney Transplantation: A Randomized Controlled Trial 81
Perioperative strategies: Taking care of the elderly patient with severe advanced comorbidities needing acute surgery 81
A RARE CAUSE OF ULCERATIVE LESION OF THE PALATE AND FEVER IN A RENAL-TRANSPLANT RECIPIENT 80
First world consensus conference on pancreas transplantation: Part I—Methods and results of literature search 80
Correction to: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (Oncogenesis, (2018), 7, 6, (46), 10.1038/s41389-018-0055-5) 79
A single-center experience with 200 dual kidney transplantations 79
Assessment of Adherence To Medical Regimen After Solid Organ Transplantation: the Experience of Padova University Hospital 78
Kidney exchange strategies: new aspects and applications with a focus on deceased donor-initiated chains 77
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? 76
[Living donor kidney transplant: the surgical procedure] 74
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 71
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: A randomized phase III study 71
Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation 71
Autosomal Dominant Polycystic Kidney Disease 70
DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys 69
Glomerulitis and endothelial cell enlargement in C4d(+) and C4d(-) acute rejections of renal transplant patients 66
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors 66
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 65
Telemedicine monitoring in the follow-up of kidney transplant recipients: consensus indications from an Italian panel of surgeons and nephrologists after the COVID-19 experience 65
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies 63
Pulse pressure variation guided fluid therapy during kidney transplantation: a randomized controlled trial 61
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 61
Outcome and quality of life of patients with augmented bladder or urinary diversion after kidney transplantation 60
Surgical complications in simultaneous pancreas and kidney transplantation (SPK) with enteric exocrine drainage and systemic venous drainage 59
Lower Urinary Tract Symptoms in Kidney Transplant Recipients and Timing of Treatment With TURP: Impact on Renal Graft Survival and Function 59
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial 59
Erratum: Optimizing utilization of kidneys from deceased donors over 60 years: Five-year outcomes after implementation of a combined clinical and histological allocation algorithm (Transplant International (2013) 26 (833)) 58
LONG TERM RESULTS OF A LARGE EXPERIENCE OF DOUBLE KIDNEY TRANSPLANTATION (DKT) PERFORMED AT A SINGLE CENTER 58
Transplantation: can a single criterion determine the use of ECD kidneys? 56
SEMEIOTICA CHIRURGICA 56
Surgical overview on kidney and pancreas transplantation 56
Laparoscopic and robot-assisted nephrectomy 55
Headache in kidney transplantation 55
Persistent Secondary Hyperparathyroidism and Vertebral Fractures in Kidney Transplantation: Role of Calcium-Sensing Receptor Polymorphisms and Vitamin D Deficiency 55
Ex Vivo open reconstruction of hilar renal artery aneurysms: a silngle-center experience 54
Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation 53
Non-compliance after solid organ transplantation: the experience of Padua University Hospital 53
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma 53
DUAL KIDNEY TRANSPLANTATION FROM ELDERLY DONORS: LONG TERM OUTCOME AND HISTOLOGICAL FEATURES 52
PROLIFERATION SIGNAL INHIBITORS (PSI) CAN BE SAFELY USED AB INITIO AFTER DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS (ED) 51
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study 51
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 51
Kidney Autotransplantation for Renal Artery Aneurysm: Case Series and a Systematic Review 51
In vitro and in vivoimmunomodulatory effects of cobalt protoporphyrin administered in combinationwith immunosuppressive drugs 51
How Long Does It Take to Acquire Mastery of Performance in Laparoscopic Living Donor Nephrectomy? A Center-Based and Surgeon-Based Operative Time CUSUM Analysis 51
Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy 50
Deceased donor-initiated Chains: first report of a successful deliberate case and its ethical implications 50
The debate on preemptive transplantation: queries and limits 50
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial 50
Refinement of a primate xenotransplantation model: application of a subcutaneously implanted port as a means of gastric nutrition 50
Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 50
Dual kidney transplantation after liver transplantation: a good option to rescue a patient from dialysis 49
Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial 49
Organ Donors with Small Renal Cancer: Report of 3 Cases 49
Everolimus Associated With Low-Dose Calcineurin Inhibitors, an Option in Kidney Transplant Recipients of Very Old Donors 49
Everolimus with very low-exposure cyclosporine A in de Novo kidney transplantation: A multicenter, randomized, controlled trial 49
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 48
Xenotransplantation of solid organs in the pig-to-primate model 48
Glomerulitis in acute rejection of renal transplant patients 48
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 48
MAXIMIZING THE SUCCESS OF TRANSPLANTATION WITH KIDNEYS FROM OLDER DONORS: LONG-TERM RESULTS OF A MULTICENTER, PROSPECTIVE STUDY 48
EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS 47
EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION: PRELIMINARY RESULTS OF A MULTICENTER STUDY 47
Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients 47
Evaluation of coronary microvascular function by coronary flow reserve (cfr) measurement in simultaneous pancreas and kidney transplantation (spk) allograft recipients 46
Therapeutic apheresis in kidney AB0 incompatible transplantation 46
Outcome of Renal Transplantation from Very Old Donors 46
Evaluation of Endothelial Cell Enlargement in Glomerulitis 46
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 45
Refinement of a primate model: Long-term enteral administration of drugs or nutritional supplementary by a subcutaneously implanted port 45
Sirolimus-Based Therapy For Kidney Transplantation From Expanded Criteria Donors 45
Physical Activity in Solid Organ Transplant Recipients: Organizational Aspects and Preliminary Results of the Italian Project 45
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study 45
Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies 45
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients 45
Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients 44
Transplantation: Optimizing outcomes in elderly kidney transplant recipients 44
CYCLOSPORIN A AND TACROLIMUS, COMBINED WITH MYCOPHENOLIC ACID, ARE EQUALLY EFFECTIVE IN PREVENTING THE ONSET OF DE NOVO ANTI-HLA ANTIBODIES 44
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials 43
Risk of renal cell cancer in people immunodepressed after solid organ transplant: Results from an Italian multicenter cohort study 43
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression 43
MicroRNAs: nuovi biomarcatori predittivi di sviluppo di insufficienza renale cronica e ipertensione arteriosa nei pazienti sottoposti a nefrectomia radicale per carcinoma renale. 43
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 42
Excellent Performance of Kidneys from Octogenarian Donors Transplanted as Dual Kidney Transplantation 42
Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-Year observational results 41
Nonadherent Behaviors After Solid Organ Transplantation 41
Totale 7.281
Categoria #
all - tutte 34.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 1 0 1 1 0 0 0 0 1 0 0 0
2022/202328 13 4 2 0 0 3 0 0 2 1 1 2
2023/2024329 1 1 0 0 0 0 0 145 34 8 33 107
2024/20251.990 187 18 21 98 214 151 542 150 234 103 120 152
2025/20265.372 383 549 957 536 303 110 630 272 1.218 212 84 118
2026/202782 82 0 0 0 0 0 0 0 0 0 0 0
Totale 7.808